INDOCONSEIndoco Remedies Limited· PharmaceuticalsLowNeutral
Announced Wed, 16 Jul · 12:15 IST

Indoco Remedies Limited has informed the Exchange about Schedule of meet

Board & Shareholder Meetings View source PDF

INDOCO · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Indoco Remedies has scheduled an earnings conference call on Thursday, July 24, 2025 at 3:30 PM IST to discuss its unaudited financial results for the quarter ended June 30, 2025 (Q1 FY26). The call will be led by Managing Director Ms. Aditi Panandikar, Joint Managing Director Mr. Sundeep V Bambolkar, and CFO Mr. Pramod Ghorpade. The call is being organized with Dolat Capital Market as the host, with dial-in numbers provided for domestic and international participants. This filing has been made under SEBI Listing Regulations to inform exchanges and investors ahead of the quarterly results announcement.

Likely market impact

Investors and analysts can expect the company to share detailed Q1 FY26 performance updates and outlook during this call. The actual quarterly results will likely be announced shortly before this call, making it a key event for assessing near-term business momentum in the stock.